Tobacco giant Philip Morris International has swept in with a superior offer for the UK’s Vectura group, outbidding Carlyle after its takeover attempt was announced in May. Vectura is recommending that its shareholders back the improved offer.
Private equity group Carlyle has been outbid in its attempt to take control of the UK’s Vectura group, after tobacco industry giant Philip Morris International submitted a superior offer of £1.50 ($2.06) per share. The offer represents a 10% increase over Carlyle’s offer of £1.36 per share.
Vectura – which has allied with Hikma to successfully develop and launch a US generic version of GlaxoSmithKline’s Advair Diskus...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
